Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001).

× No keyword cloud information.

94 in total

Review 1. Perioperative care for patients with rheumatic diseases.

Authors: Bharath M Akkara Veetil; Tim Bongartz
Journal: Nat Rev Rheumatol Date: 2011-11-15 Impact factor: 20.543

2. Perioperative management of patients with connective tissue disease.

Authors: Susan M Goodman; Mark P Figgie; C Ronald Mackenzie
Journal: HSS J Date: 2010-08-17

3. Life threatening intra-abdominal sepsis in patients on anti-TNF-alpha therapy.

Authors: S Goode; G Tierney; C Deighton
Journal: Gut Date: 2005-11-18 Impact factor: 23.059

Review 4. TNF-blocking therapy in rheumatoid arthritis and ankylosing spondylitis: why is cost-effectiveness a major issue?

Authors: Sonja Merkesdal; Henning Zeidler
Journal: Curr Rheumatol Rep Date: 2005-08 Impact factor: 4.592

5. Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis.

Authors: S Rajakulendran; K Gadsby; D Allen; S O'Reilly; C Deighton
Journal: Ann Rheum Dis Date: 2006-12 Impact factor: 19.103

6. Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model.

Authors: I-Tsu Chyuan; Hwei-Fang Tsai; Horng-Tay Tzeng; Chi-Chang Sung; Chien-Sheng Wu; Pei-Jer Chen; Ping-Ning Hsu
Journal: Cell Mol Immunol Date: 2015-02-09 Impact factor: 11.530

Review 7. What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.

Authors: W G Dixon; D P M Symmons
Journal: Ann Rheum Dis Date: 2007-01-24 Impact factor: 19.103

8. [Recommendations of the German Society for Rheumatology on the perioperative approach under therapy with DMARDs and biologicals in inflammatory rheumatic diseases].

Authors: K Krüger; K Albrecht; S Rehart; R Scholz
Journal: Z Rheumatol Date: 2014-02 Impact factor: 1.372

9. Re-challenge with etanercept in patients with etanercept-induced neutropenia.

Authors: Muhammad Haroon; Mary Daly; Sinead Harney
Journal: Clin Rheumatol Date: 2011-08-05 Impact factor: 2.980

10. [Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases].

Authors: R Diel; B Hauer; R Loddenkemper; B Manger; K Krüger
Journal: Z Rheumatol Date: 2009-07 Impact factor: 1.372